Genor Biopharma Holdings Limited (HK:6998) has released an update.
Genor Biopharma Holdings Limited has announced the resignation of Mr. Zhou Honghao as an independent non-executive Director effective from 18 September 2024, due to his inability to continue under new administrative measures. This resignation leaves the company short of meeting the Hong Kong Stock Exchange’s listing requirements regarding the number of independent directors and committee members. The company is actively seeking a suitable replacement to rectify the non-compliance issue within three months of the effective resignation date.
For further insights into HK:6998 stock, check out TipRanks’ Stock Analysis page.